MX2018000654A - Producto de proteina adhesiva de mejillon y sus usos para inhibir la inflamacion de la mucosa. - Google Patents
Producto de proteina adhesiva de mejillon y sus usos para inhibir la inflamacion de la mucosa.Info
- Publication number
- MX2018000654A MX2018000654A MX2018000654A MX2018000654A MX2018000654A MX 2018000654 A MX2018000654 A MX 2018000654A MX 2018000654 A MX2018000654 A MX 2018000654A MX 2018000654 A MX2018000654 A MX 2018000654A MX 2018000654 A MX2018000654 A MX 2018000654A
- Authority
- MX
- Mexico
- Prior art keywords
- cancer
- catarrh
- map
- inhibiting
- application
- Prior art date
Links
- 108010004563 mussel adhesive protein Proteins 0.000 title abstract 5
- 239000003988 mussel adhesive protein Substances 0.000 title abstract 5
- 201000009240 nasopharyngitis Diseases 0.000 title abstract 3
- NOOLISFMXDJSKH-UHFFFAOYSA-N p-menthan-3-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 title abstract 3
- 230000002401 inhibitory effect Effects 0.000 title abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 2
- 230000004054 inflammatory process Effects 0.000 abstract 2
- 201000009030 Carcinoma Diseases 0.000 abstract 1
- 206010008342 Cervix carcinoma Diseases 0.000 abstract 1
- 206010014733 Endometrial cancer Diseases 0.000 abstract 1
- 206010014759 Endometrial neoplasm Diseases 0.000 abstract 1
- 208000004145 Endometritis Diseases 0.000 abstract 1
- 208000004232 Enteritis Diseases 0.000 abstract 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 abstract 1
- 208000007882 Gastritis Diseases 0.000 abstract 1
- 201000003741 Gastrointestinal carcinoma Diseases 0.000 abstract 1
- 206010023825 Laryngeal cancer Diseases 0.000 abstract 1
- 201000008197 Laryngitis Diseases 0.000 abstract 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 abstract 1
- 208000001894 Nasopharyngeal Neoplasms Diseases 0.000 abstract 1
- 206010061306 Nasopharyngeal cancer Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 abstract 1
- 206010030216 Oesophagitis Diseases 0.000 abstract 1
- 206010033078 Otitis media Diseases 0.000 abstract 1
- 201000007100 Pharyngitis Diseases 0.000 abstract 1
- 208000003251 Pruritus Diseases 0.000 abstract 1
- 206010037660 Pyrexia Diseases 0.000 abstract 1
- 208000005718 Stomach Neoplasms Diseases 0.000 abstract 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 abstract 1
- 208000006374 Uterine Cervicitis Diseases 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 206010006451 bronchitis Diseases 0.000 abstract 1
- 201000010881 cervical cancer Diseases 0.000 abstract 1
- 206010008323 cervicitis Diseases 0.000 abstract 1
- 201000000787 conjunctival cancer Diseases 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 210000000959 ear middle Anatomy 0.000 abstract 1
- 208000023042 endomyometritis Diseases 0.000 abstract 1
- 201000004101 esophageal cancer Diseases 0.000 abstract 1
- 208000006881 esophagitis Diseases 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 206010017758 gastric cancer Diseases 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 201000002313 intestinal cancer Diseases 0.000 abstract 1
- 206010023841 laryngeal neoplasm Diseases 0.000 abstract 1
- 201000005202 lung cancer Diseases 0.000 abstract 1
- 208000020816 lung neoplasm Diseases 0.000 abstract 1
- 229940127554 medical product Drugs 0.000 abstract 1
- 201000005443 oral cavity cancer Diseases 0.000 abstract 1
- 206010039083 rhinitis Diseases 0.000 abstract 1
- 238000004659 sterilization and disinfection Methods 0.000 abstract 1
- 201000011549 stomach cancer Diseases 0.000 abstract 1
- 208000003265 stomatitis Diseases 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Otolaryngology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Reproductive Health (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Genetics & Genomics (AREA)
- Nutrition Science (AREA)
- Hematology (AREA)
- Materials Engineering (AREA)
- Immunology (AREA)
- Marine Sciences & Fisheries (AREA)
- Ophthalmology & Optometry (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Physiology (AREA)
- Urology & Nephrology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2015/087011 WO2017028025A1 (zh) | 2015-08-14 | 2015-08-14 | 贻贝粘蛋白产品及其抑制粘膜炎症的应用 |
| PCT/CN2016/095364 WO2017028777A1 (zh) | 2015-08-14 | 2016-08-15 | 贻贝粘蛋白产品及其抑制粘膜炎症的应用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2018000654A true MX2018000654A (es) | 2018-07-06 |
Family
ID=58050454
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018000654A MX2018000654A (es) | 2015-08-14 | 2016-08-15 | Producto de proteina adhesiva de mejillon y sus usos para inhibir la inflamacion de la mucosa. |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10485848B2 (enExample) |
| EP (1) | EP3335739B1 (enExample) |
| JP (1) | JP6816098B2 (enExample) |
| KR (1) | KR102708321B1 (enExample) |
| CN (1) | CN108348636B (enExample) |
| AU (1) | AU2016309397B2 (enExample) |
| CA (1) | CA2995549C (enExample) |
| DK (1) | DK3335739T3 (enExample) |
| MA (1) | MA42629A (enExample) |
| MX (1) | MX2018000654A (enExample) |
| SG (1) | SG11201800578YA (enExample) |
| WO (2) | WO2017028025A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201800440SA (en) | 2015-07-20 | 2018-02-27 | Bengt I Samuelsson Institute Of Life Science Res | Mussel adhesive protein product and applications thereof in suppression of skin inflammations |
| MX2018000335A (es) | 2015-07-20 | 2018-05-22 | Bengt I Samuelsson Institute Of Life Science Res | Aplicaciones de los productos de la proteina adhesiva del mejillon para el tratamiento y la prevencion de enfermedades relacionadas con la melanina. |
| WO2017011986A1 (zh) | 2015-07-20 | 2017-01-26 | 赵兵 | 一种空气过滤装置 |
| WO2017028025A1 (zh) | 2015-08-14 | 2017-02-23 | 江阴市本特塞缪森生命科学研究院有限公司 | 贻贝粘蛋白产品及其抑制粘膜炎症的应用 |
| CN110139662B (zh) * | 2017-07-05 | 2022-03-18 | 江阴贝瑞森制药有限公司 | 肽的抗炎用途 |
| MA52794A (fr) * | 2018-05-28 | 2021-04-14 | Jiangyin Usun Pharmaceutical Co Ltd | Nouvelle utilisation pharmaceutique |
| WO2020182139A1 (zh) * | 2019-03-12 | 2020-09-17 | 杭州英健生物科技有限公司 | 消化道黏膜保护胶 |
| EP4028409A4 (en) * | 2019-09-14 | 2023-10-11 | EnliTISA (Shanghai) Pharmaceutical Co., Ltd. | NEW PEPTIDES |
| CN114929726A (zh) * | 2019-12-02 | 2022-08-19 | 艾缇亚(上海)制药有限公司 | 新肽及其在炎症治疗中的用途 |
| KR102596264B1 (ko) | 2020-11-30 | 2023-11-01 | 주식회사 바이오빛 | 기능성 펩티드가 결합된 생체적합 폴리펩티드를 포함하는 염증 질환의 억제용 조성물 |
| CN114588267A (zh) * | 2020-12-04 | 2022-06-07 | 江苏恒瑞医药股份有限公司 | 一种含酰胺类局部麻醉药的药物组合物 |
| CN112695064B (zh) * | 2021-02-01 | 2023-06-16 | 大连海洋大学 | 从海洋腹足类黏液中提取的抗肝癌和抗肝纤维化的低聚肽 |
| JP2022172889A (ja) * | 2021-05-07 | 2022-11-17 | 大和製罐株式会社 | 吐出容器入り薬液 |
| CN115778926A (zh) * | 2023-01-30 | 2023-03-14 | 南京天纵易康生物科技股份有限公司 | 一种含贻贝粘蛋白的可降解唇部护理贴剂及其制备方法 |
| CN118059215B (zh) * | 2024-01-23 | 2024-08-30 | 海南美安生物医药科技有限公司 | 一种妇科温敏型原位凝胶及其制备和应用 |
| WO2025195444A1 (en) | 2024-03-20 | 2025-09-25 | Enlitisa (Shanghai) Pharmaceutical Co., Ltd. | New use of peptides derived from vasoactive intestinal peptide |
| CN118236471B (zh) * | 2024-03-21 | 2025-08-19 | 湖南天根乐微君科技有限公司 | 一种用于改善鼻炎症状和鼻腔清洗的组合物及其制备方法和应用 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5605938A (en) | 1991-05-31 | 1997-02-25 | Gliatech, Inc. | Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate |
| RU2043109C1 (ru) | 1992-03-17 | 1995-09-10 | Маина Александровна Бичурина | Способ ингибиции вируса гриппа серотипов а и в |
| CN1112831A (zh) | 1994-05-30 | 1995-12-06 | 乌力吉 | 含蜗牛提取液的长效多功能营养护肤水及其制法 |
| NZ314867A (en) * | 1997-05-21 | 1999-04-29 | Mcfarlane Lab New Zealand Ltd | Glucosamine and mussel extract compositions for use as anti-inflammatories |
| WO1999064580A1 (en) | 1998-06-10 | 1999-12-16 | Georgia Tech Research Corporation | Microneedle devices and methods of manufacture and use thereof |
| US20020018787A1 (en) | 1999-05-21 | 2002-02-14 | Roger V. Kendall | Methods and compositions for modulating immune response and for the treatment of inflammatory disease |
| EP1408999B1 (en) | 1999-07-21 | 2008-03-12 | Bomac Research Limited | Compositions addressing inflammation and/or degenerative disorders |
| WO2001012146A1 (en) | 1999-08-16 | 2001-02-22 | Playtex Products, Inc. | Sunscreen lotion or spray composition |
| US7074433B2 (en) | 2001-03-30 | 2006-07-11 | Council Of Scientific And Industrial Research | Process for the cure and control of Diabetes mellitus using natural products from Perna viridis |
| US6770302B2 (en) | 2001-03-30 | 2004-08-03 | Department Of Biotechnology | Indian green mussel (Perna viridis) as a source of anti-HIV activity |
| US6905710B2 (en) | 2001-08-31 | 2005-06-14 | Council Of Scientific And Industrial Research | Pharmaceutical composition useful for inhibition of osteoclast formation and a process for the extraction of mussel hudrolysate from indian green mussel |
| US20060275370A1 (en) * | 2002-07-25 | 2006-12-07 | Yih-Lin Chung | Method and compositions for treatment of epithelial damage |
| US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
| CA2553775A1 (en) * | 2004-01-20 | 2005-08-11 | Richard F. Harty | Compositions and methods of treatment for inflammatory diseases |
| CN101348520B (zh) | 2007-12-14 | 2011-10-12 | 顾铭 | 一种使用混合吸附色谱分离纯化贻贝粘蛋白的方法 |
| CN101348518B (zh) | 2007-12-14 | 2011-09-28 | 顾铭 | 一种使用羧甲基离子交换色谱纯化贻贝粘蛋白的方法 |
| KR101022884B1 (ko) * | 2009-06-12 | 2011-03-16 | 주식회사 원바이오젠 | 약물층을 포함하는 폴리우레탄 폼 드레싱제 및 그 제조방법 |
| CN101585874B (zh) | 2009-06-30 | 2012-08-22 | 江阴贝瑞森生化技术有限公司 | 一种使用盐析和透析分离纯化贻贝粘蛋白的方法 |
| JP2012526155A (ja) | 2009-08-25 | 2012-10-25 | ポステック アカデミー−インダストリー ファンデーション | イガイ接着蛋白質またはその変異体に陰イオン性高分子が含まれたコアセルベート |
| KR101147847B1 (ko) | 2010-06-02 | 2012-05-24 | 건국대학교 산학협력단 | 패류 유래 기능성 펩티드의 분리 정제 방법 및 기능성 펩티드의 용도 |
| CN101991840B (zh) | 2010-09-26 | 2012-09-05 | 浙江海洋学院 | 抗前列腺癌贻贝酶解提取物的制备方法及应用 |
| KR101384746B1 (ko) * | 2011-08-24 | 2014-04-14 | 포항공과대학교 산학협력단 | 홍합 접착 단백질을 이용한 다양한 기능성 생체분자의 표면 고정화 |
| CN102302417B (zh) | 2011-09-13 | 2012-12-26 | 佛山市安安美容保健品有限公司 | 一种含有海洋生物活性物质的全效防晒乳液 |
| WO2013143077A1 (zh) * | 2012-03-28 | 2013-10-03 | 江阴贝瑞森生化技术有限公司 | 使用多模式色谱纯化贻贝粘蛋白的方法 |
| WO2014186937A1 (zh) * | 2013-05-20 | 2014-11-27 | Gao Min | 贻贝粘蛋白凝胶的制备方法、贻贝粘蛋白凝胶及其应用 |
| CN103520766A (zh) * | 2013-09-25 | 2014-01-22 | 高敏 | 贻贝粘蛋白液体产品、其制备方法及其应用 |
| CN104323927A (zh) | 2014-11-06 | 2015-02-04 | 济南星河康泰贸易有限公司 | 贻贝粘蛋白在制备皮肤美容化妆品上的应用 |
| CN104645313A (zh) * | 2015-01-28 | 2015-05-27 | 南京航空航天大学 | 一种修复止痒贻贝粘蛋白凝胶剂及其制备方法 |
| CN104645320A (zh) | 2015-01-28 | 2015-05-27 | 南京航空航天大学 | 一种创面修复用贻贝粘蛋白凝胶剂及其制备方法和应用 |
| CN104857552B (zh) | 2015-05-18 | 2018-08-10 | 赵明 | 一种止血贴及其制备方法 |
| WO2017011986A1 (zh) | 2015-07-20 | 2017-01-26 | 赵兵 | 一种空气过滤装置 |
| SG11201800440SA (en) | 2015-07-20 | 2018-02-27 | Bengt I Samuelsson Institute Of Life Science Res | Mussel adhesive protein product and applications thereof in suppression of skin inflammations |
| MX2018000335A (es) | 2015-07-20 | 2018-05-22 | Bengt I Samuelsson Institute Of Life Science Res | Aplicaciones de los productos de la proteina adhesiva del mejillon para el tratamiento y la prevencion de enfermedades relacionadas con la melanina. |
| WO2017028025A1 (zh) | 2015-08-14 | 2017-02-23 | 江阴市本特塞缪森生命科学研究院有限公司 | 贻贝粘蛋白产品及其抑制粘膜炎症的应用 |
-
2015
- 2015-08-14 WO PCT/CN2015/087011 patent/WO2017028025A1/zh not_active Ceased
-
2016
- 2016-08-15 WO PCT/CN2016/095364 patent/WO2017028777A1/zh not_active Ceased
- 2016-08-15 KR KR1020187003844A patent/KR102708321B1/ko active Active
- 2016-08-15 MX MX2018000654A patent/MX2018000654A/es unknown
- 2016-08-15 AU AU2016309397A patent/AU2016309397B2/en active Active
- 2016-08-15 US US15/751,551 patent/US10485848B2/en active Active
- 2016-08-15 EP EP16836641.7A patent/EP3335739B1/en active Active
- 2016-08-15 DK DK16836641.7T patent/DK3335739T3/da active
- 2016-08-15 SG SG11201800578YA patent/SG11201800578YA/en unknown
- 2016-08-15 CN CN201680041312.4A patent/CN108348636B/zh active Active
- 2016-08-15 MA MA042629A patent/MA42629A/fr unknown
- 2016-08-15 JP JP2018501271A patent/JP6816098B2/ja active Active
- 2016-08-15 CA CA2995549A patent/CA2995549C/en active Active
-
2019
- 2019-10-01 US US16/589,346 patent/US11458190B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US11458190B2 (en) | 2022-10-04 |
| CN108348636B (zh) | 2021-05-25 |
| US20180243371A1 (en) | 2018-08-30 |
| JP6816098B2 (ja) | 2021-01-20 |
| SG11201800578YA (en) | 2018-02-27 |
| MA42629A (fr) | 2018-06-20 |
| WO2017028025A1 (zh) | 2017-02-23 |
| AU2016309397A1 (en) | 2018-03-01 |
| JP2019501108A (ja) | 2019-01-17 |
| US10485848B2 (en) | 2019-11-26 |
| KR102708321B1 (ko) | 2024-09-23 |
| DK3335739T3 (en) | 2023-11-13 |
| HK1257176A1 (en) | 2019-10-18 |
| AU2016309397B2 (en) | 2020-10-22 |
| CA2995549A1 (en) | 2017-02-23 |
| EP3335739B1 (en) | 2023-10-04 |
| CN108348636A (zh) | 2018-07-31 |
| EP3335739A4 (en) | 2019-04-03 |
| KR20180033517A (ko) | 2018-04-03 |
| US20200101135A1 (en) | 2020-04-02 |
| CA2995549C (en) | 2024-01-02 |
| WO2017028777A1 (zh) | 2017-02-23 |
| EP3335739A1 (en) | 2018-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2018000654A (es) | Producto de proteina adhesiva de mejillon y sus usos para inhibir la inflamacion de la mucosa. | |
| WO2017134302A3 (en) | Targeted therapeutic agents and uses thereof | |
| MX2020001555A (es) | Preparaciones terapéuticas de glicanos y métodos relacionados con estas. | |
| NZ719905A (en) | Bicyclic heterocycle compounds and their uses in therapy | |
| WO2016080810A3 (ko) | 바이구아나이드 화합물 및 이의 용도 | |
| MX2020004420A (es) | Polipeptidos efectores de la subunidad a de la toxina shiga resistentes a la disociacion por proteasa y moleculas dirigidas a las celulas que los comprenden. | |
| PH12018500284A1 (en) | 5-bromo-2,6-di-(1h-pyrazol-1-yl)pyrimidin-4-amine for use in the treatment of cancer | |
| WO2016172657A3 (en) | Glycan therapeutics and methods of treatment | |
| MX2014009757A (es) | Derivados de isoindolina, composiciones farmaceuticas que los contienen y su uso en terapia. | |
| UA105036C2 (uk) | Амінотетралінові похідні, фармацевтична композиція, яка їх містить, і їх застосування в терапії | |
| MX2016000825A (es) | Glicosidos de esteviol. | |
| AU2015329999B2 (en) | 17a,21-diesters of cortexolone for use in the treatment of tumors | |
| ZA202004023B (en) | 1,2,4-oxadiazole derivatives as histone deacetylase 6 inhibitors | |
| MX2009014235A (es) | 4-bencilaminoquinolonas, composiciones farmaceuticas que las contiene y su uso. | |
| WO2014141210A3 (en) | Multifunctional immature dental pulp stem cells and therapeutic applications | |
| MX2016004936A (es) | Derivados de aminocromano, aminotiocromano y amino-1,2,3,4-tetrahi droquinilina, composiciones farmaceuticas que los contienen, y su uso en terapia. | |
| MX2015013148A (es) | Nuevos compuestos de bencensulfonamida, metodo para sintetizar los mismos, y uso de los mismos en medicina asi como tambien en cosmeticos. | |
| CY1122892T1 (el) | Παραγωγα 3-(καρβοξυμεθυλ)-8-αμινο-2-οξο-1,3-διαζα-σπειρο-[4.5]-δεκανιου | |
| MX2016004934A (es) | Derivados de aminotetralina y aminoindano, composiciones farmaceuticas que los contienen, y su uso en terapia. | |
| AU2017269673A1 (en) | Pyridine dicarboxamide derivatives as bromodomain inhibitors | |
| MX378607B (es) | Derivados de 3-((hetero)aril)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano. | |
| MX2019010218A (es) | Derivados de pirazol como inhibidores de bromodominio. | |
| AU2018256668A1 (en) | Combination therapy comprising an inhibitor of JAK, CDK and PIM | |
| MX2015014309A (es) | Modulador de sabor y metodo para utilizar el mismo. | |
| EA201791526A1 (ru) | Натуральная композиция подсластителя из ло хан го |